Trials / Completed
CompletedNCT03956212
Inflammatory Mediators in Erythema Migrans
Inflammatory Proteins, Gene Polymorphisms, and Transcriptome Profiles in Patients With Erythema Migrans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- University Medical Centre Ljubljana · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with erythema migrans to gain better insight into pathogenesis of early Lyme borreliosis and to define new immune modulators that could serve as biomarkers of disease activity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Doxycycline 7 days | Patient will be treated with doxycycline orally, 100 mg, bid, 7 days |
| DRUG | Doxycycline 14 days | Patient will be treated with doxycycline orally, 100 mg, bid, 14 days |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2019-12-31
- Completion
- 2020-10-31
- First posted
- 2019-05-20
- Last updated
- 2020-11-03
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT03956212. Inclusion in this directory is not an endorsement.